Close Menu

NEW YORK — The US Food and Drug Administration on Tuesday granted separate Emergency Use Authorizations for SARS-CoV-2 antibody tests developed by DiaSorin, NanoEntek America, and Nirmidas Biotech.

DiaSorin's Liaison SARS-CoV-2 IgM Assay is an indirect chemiluminescent immunoassay designed to detect immunoglobulin M (IgM) antibodies against the virus in serum and plasma. It runs on the Saluggia, Italy-based company's Liaison XL Analyzer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.